Summary
Background
Prominent early features of COVID-19 include severe, often clinically silent, hypoxia and a pronounced reduction in B cells, the latter important in defence against SARS-CoV-2. This presentation resembles the phenotype of mice with VHL-deficient B cells, in which Hypoxia-Inducible Factors are constitutively active, suggesting hypoxia might drive B cell abnormalities in COVID-19.
Methods
Detailed B cell phenotyping was undertaken by flow-cytometry on longitudinal samples from patients with COVID-19 across a range of severities (NIHR Cambridge BioResource). The impact of hypoxia on the transcriptome was assessed by single-cell and whole blood RNA sequencing analysis. The direct effect of hypoxia on B cells was determined through immunisation studies in genetically modified and hypoxia-exposed mice.
Findings
We demonstrate the breadth of early and persistent defects in B cell subsets in moderate/severe COVID-19, including reduced marginal zone-like, memory and transitional B cells, changes also observed in B cell VHL-deficient mice. These findings were associated with hypoxia-related transcriptional changes in COVID-19 patient B cells, and similar B cell abnormalities were seen in mice kept in hypoxic conditions.
Interpretation
Hypoxia may contribute to the pronounced and persistent B cell pathology observed in acute COVID-19 pneumonia. Assessment of the impact of early oxygen therapy on these immune defects should be considered, as their correction could contribute to improved outcomes.
Funding
Evelyn Trust, Addenbrooke’s Charitable Trust, UKRI/NIHR, Wellcome Trust
【저자키워드】 COVID-19, hypoxia, B cells, lymphopenia, 【초록키워드】 Transcriptome, SARS-CoV-2, pathology, Pneumonia, severity, transitional B cells, memory, B cell, outcomes, Whole blood, mice, RNA sequencing, Oxygen therapy, phenotype, Trust, assessment, change, funding, single-cell, breadth, Analysis, COVID-19 patient, Factor, NIHR, hypoxic conditions, Wellcome Trust, acute COVID-19, finding, abnormality, Cambridge BioResource, flow-cytometry, feature, include, clinically, reduced, was determined, contribute, reduction in, silent, transcriptional change, B cell subset, immune defect, patients with COVID-19, Prominent, 【제목키워드】 B cell,